This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Pathophysiology, Epidemiology and Long Covid
Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
PLOS Medicine:2022: July 19 Full text
Characteristics of patients referred to a cardiovascular disease clinic for post-acute sequelae of SARS-CoV-2 infection.
American Heart Journal Plus: Cardiology Research and Practice: 2022: July 13 Full text
Association of omicron vs wild-type SARS-CoV-2 variants with hospital-onset SARS-CoV-2 infections in a US regional hospital system.
JAMA:2022: June 15 Full text
Clinical characteristics and outcomes of critically ill patients with 1, 2 and 3 doses of vaccination against COVID-19 in Australia. AUS
Internal Medicine Journal:2022: July 16 Full text
Vaccines
BNT162b2 vaccine effectiveness in chronic kidney disease patients – an observational study.
Clinical Kidney Journal:2022: July 4 Full text
BNT162b2 vaccine effectiveness against Omicron in children 5 to 11 years of age.
New England Journal of Medicine:2022: July 21 Full text
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden.
Lancet Regional Health: Europe: 2022: July 13 Full text
COVID vaccination can be completed in subjects with a history of allergic reactions to the vaccines or their components – experience from a specialist clinic in South Australia. AUS
Internal Medicine Journal:2022; July 18 Full text
Vaccine Adverse Effects
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
BMJ:2022: July 13 Full text
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
BMJ:2022: July 13 Full text
Immunology
Protection of SARS-CoV-2 natural infection against reinfection with the Omicron BA.4 or BA.5 subvariants.
MedRxiv:2022: July 12 Full text
Long-term immune response to SARS-CoV-2 infection among children and adults after mild infection.
JAMA Network OPen:2022: July 13 Full text
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.
Immunological Reviews:2022: June 22 Full text
Duration of shedding of culturable virus in SARS-CoV-2 Omicron (BA.1) infection.
New England Journal of Medicine:2022: July 21 Full text
